Julie Scallen > Latham & Watkins LLP > Boston, United States > Lawyer Profile

Latham & Watkins LLP
200 CLARENDON STREET
BOSTON MA 02116
MASSACHUSETTS
United States

Work Department

Julie Scallen is a partner in the Boston office of Latham & Watkins and serves as Corporate Department Chair for the Boston office. She focuses her practice on mergers and acquisitions and private equity transactions. Ms. Scallen represents public and private companies and private equity funds in acquisitions, leveraged buyouts, dispositions, private equity and venture capital financings, strategic alliances, joint ventures and licensing transactions.

Lawyer Rankings

United States > Healthcare > Life sciences

(Leading lawyers)

Julie Scallen Latham & Watkins LLP

Latham & Watkins LLP provides a diverse offering to a number of clients, including biopharmaceutical and biotech start-up companies, and medical device manufacturers. The team advises on a wide range of matters, including white collar investigations, IP disputes, and corporate transactions. Based in California, Shayne Kennedy is particularly adept at advising on public and private securities offerings, and life sciences M&A, while Judith Hasko has a great deal of experience in the execution of strategic licensing alliances, often assisting life sciences companies with securing funding. Arlene Lee Chow works out of the New York office, and routinely acts for biotech and pharmaceutical companies in IP and patent cases. Chicago-based Terra Reynolds is noted for her expertise in government and internal investigations, while the Boston-based Julie Scallen focuses on joint ventures and venture capital transactions within the life sciences and med-tech industries. In Washington DC, John Manthei maintains an FDA regulatory practice with a distinct emphasis on the medical device and biotech industries; Ben Haas has extensive experience in assisting clients with FDA submissions and pre-clinical testing, and Elizabeth Richards often negotiates contracts with clinical trial sites.